NFKB1 and breast carcinoma: Activation of the canonical nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) pathway may also be implicated in the promotion of the dormant phenotype in breast cancer cells expressing estrogen receptors (ERs) [25].